Quantitative structure-activity relationship studies on cyclic cyanoguanidines acting as HIV-1 protease inhibitors

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 11, 1999, Pages 2549-2553

  Gupta, S P ^a   Suresh Babu, M ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Cyclic cyanoguanidines; Cyclic urea derivatives; HIV 1 protease inhibitors; Quantitative structure activity relationship

Indexed keywords

ANTIRETROVIRUS AGENT; GUANIDINE DERIVATIVE; PROTEINASE INHIBITOR; UREA DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

CELLS, CULTURED; CYCLIC GMP; GUANIDINES; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MODELS, BIOLOGICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033491170     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00175-3     Document Type: Article

References (17)

1. Kohl N.E., Emini N.A., Schleif W.A., Davis L.J., Heimbach J.C., Dixon R.A.F., Scolnick E.M., Sigal I.S. Proc. Natl. Acad. Sci. USA. 85:1988;4686.
2. Seelmeier S., Schmidt H., Turk V., von der Helm K. Proc. Natl. Acad. Sci. USA. 85:1988;6612.
3. Wlodawer A., Erickson J.W. Annu. Rev. Biochem. 62:1993;543.
4. Applet K. Perspec. Drug Discovery Des. 1:1993;23.
5. Boehme R.E., Borthwick A.D., Wyatt P.G. Annu. Rep. Med. Chem. 30:1995;139.
6. Romines K.R., Thaisrivongs S. Drugs Future. 20:1995;377.
7. Olson G.L., Bolin D.R., Bonner M.P., Bos M., Cook C.M., Fry D.C., Graves B.J., Hatada M., Hill D.E., Kahn M., Madison V.S., Rusiecki V.K., Sarabu R., Sepinwall J., Vincent G.P., Voss M.E. J. Med. Chem. 36:1993;3039.
8. See for example: Maligres, P. E.; Upadhyay, V.; Rossen, K.; Cianciosi, S. J.; Purick, R. M.; Eng, K. K.; Reamer, R. A.; Askin, D.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1995, 36, 2195.
9. Lam P.Y.S., Jadhav P.K., Eyermann C.J., Hodge C.N., Ru Y., Bacheler L.T., Meek J.L., Otto M.J., Raynner M.M., Wong N.Y., Chang C.H., Wever P.C., Jackson D.A., Sharpe T.R., Erickson-Viitanen S. Science. 263:1994;380.
10. Nugiel D.A., Jacobs K., Worley T., Patel M., Kaltenbatch III R.F., Meyer D.T., Jadhav P.K., DeLucca G.V., Smyser T.E., Klabe R.M., Bacheler L.T., Rayner M.M., Seith S.P. J. Med. Chem. 39:1996;2156.
11. Lam P.Y.S., Ru Y., Jadhav P.K., Aldrich P.E., DeLucca G.V., Eyerman C.J., Chang C.H., Emmett G., Holler E.R., Danekar W.F., Li L., Confalone P.N., McHugh R.J., Han Q., Li R., Markwader J.A., Seitz S.P., Sharpe T.R., Bacheler L.T., Rayner M.M., Klabe R.M., Shum L., Winslow D.L., Kornhauser D.M., Jackson D.A., Erickson-Viitanen S., Hodge C.N. J. Med. Chem. 39:1996;3514.
12. Jadhav P.K., Woerner F.J., Lam P.Y.S., Hodge C.N., Eyermann C.J., Man H.-W., Danekar W.F., Bacheler L.T., Rayner M.M., Meek J.L., Erickson-Viitanen S., Jackson D.A., Calabrese J.C., Schadt M., Chang C.H. J. Med. Chem. 41:1998;1446.
13. Jacobson H., Yasargil K., Winslow D.L., Craig J.C., Krohn A., Duncan I.B., Mous J. Virology. 206:1995;527.
14. Ridky T., Leis J. J. Biol. Chem. 270:1995;29621.
15. Gupta S.P., Babu M.S., Garg R., Sowmya S. J. Enzyme Inhibn. 13:1998;399.
16. Ala P.J., Huston E.E., Klabe R.M., McCabe D.D., Duke J.L., Rizzo C.J., Korant B.E., De Loskey J.R., Lam P.Y.S., Hodge C.N., Chang C.-H. Biochemistry. 36:1997;1573.
17. Hansch C., Leo A.J. Substituent constants for correlation analysis in chemistry and biology. 1979;John Wiley, New York.